-- Valeant Raises Offer for Obagi Medical After Merz Bid
-- B y   B r u c e   R u l e
-- 2013-04-03T12:16:07Z
-- http://www.bloomberg.com/news/2013-04-02/obagi-medical-surges-on-new-takeover-offer-los-angeles-mover.html
Valeant Pharmaceuticals
International Inc. (VRX)  raised its offer for Obagi Medical Products
Inc. to $24 a share from $19.75, after the maker of prescription
skin care products received a competing bid from closely held
Merz Pharma Group.  Obagiâ€™s board unanimously approved the higher cash offer
from Valeant, the two companies said in a statement today. The
bid values Obagi at about $417 million. Frankfurt-based Merz
offered offered $22 a share.  Obagi, based in  Long Beach , California, makes Nu-Derm, an
anti-aging treatment. The product had about $62 million in sales
last year.  To contact the reporter on this story:
Bruce Rule in New York at 
 brule1@bloomberg.net ;  To contact the editor responsible for this story:
Reg Gale at   rgale5@bloomberg.net  